
Asthma remains one of the most widespread chronic respiratory conditions in India — affecting both children and adults across age groups. Despite being manageable, misconceptions and delayed medical intervention often worsen its impact. During my recent visit to Sparsh Super Speciality Lung Clinic in Mumbai, I had the privilege of meeting Dr. Parthiv Shah, a highly regarded Asthma Specialist in Mumbai, whose work in respiratory care offers hope and clarity to thousands struggling with chronic breathlessness and allergic airway diseases.
Dr. Parthiv Shah’s journey into pulmonary medicine began with a firm belief — that early diagnosis and patient education can change the trajectory of chronic lung diseases. A graduate of one of Mumbai’s premier medical institutions, he earned his MD in Pulmonary Medicine and went on to receive specialized training in asthma management, bronchoscopy, and allergy diagnostics.
With over 15 years of experience, Dr. Shah has built a reputation as one of Mumbai’s most trusted names in respiratory care. At his well-equipped Sparsh Super Speciality Lung Clinic, he treats a wide spectrum of respiratory conditions including asthma, chronic bronchitis, COPD, interstitial lung disease (ILD), and post-COVID lung fibrosis.
The clinic features advanced diagnostic infrastructure, including Pulmonary Function Testing (PFT), Allergy Skin Testing, Bronchoscopy, and Sleep Study (Polysomnography) facilities — enabling a comprehensive, one-stop solution for respiratory ailments.
Dr. Shah explains asthma as a “chronic inflammatory condition of the airways” that leads to episodes of coughing, wheezing, and breathlessness, often triggered by allergens, pollution, or stress. “Asthma cannot be cured, but it can be controlled,” he emphasizes, “and the key lies in personalized management, not just medication.”
He also highlights the modern classification of asthma — mild, moderate, and severe persistent asthma — where treatment plans vary from inhaled corticosteroids to biological therapies that target specific inflammatory pathways.
India is home to several distinguished pulmonologists advancing asthma research and treatment. Dr. Arvind Kate and Dr. Nitesh Gupta are recognized for their contributions to pulmonary rehabilitation and airway disease management.
Globally, doctors such as Dr. Monica Kraft and Dr. Peter Gibson are pioneers in asthma phenotyping and innovative treatment protocols. Their research underscores the importance of early intervention, patient education, and lifestyle management — principles that align closely with Dr. Shah’s approach to care.
Modern asthma management has evolved significantly. Dr. Shah outlines a structured approach involving: